Diagnostic Kit for Serum Amyloid A(SAA) (Time-resolved Fluorescence Immunochromatographic Assay)

Primary DI

06974521000730

Basic UDI-DI Code

B-06974521000730

Reference

SUPF039025

Device Types

Single use

Regulation

Eu Ivdd

Classification

Eu Ivd General

Status

On The Market

Manufacturer

Shenzhen Superbio Technology Co.,Ltd.

This test is suitable for in vitro quantitative detection of the concentration of human serum amyloid A (SAA) in human serum, plasma, whole blood. The product is used for auxiliary diagnosis of patients' inflammation and other related diseases. Serum amyloid A (SAA) is a polymorphic protein family encoded by polygenes, and the precursor material of tissue amyloid A is a type of acute amyloid protein. In the acute phase of inflammation or infection, it increases rapidly within 4~6h and decreases rapidly in the recovery period of the disease. Currently, elevated serum SAA is detected in bacterial and viral infections, atherosclerosis, coronary heart disease, acute graft rejection, tumor and other diseases. The sensitivity of SAA is higher than that of CRP for some diseases, such as virus infection, graft rejection, coronary heart disease, etc., which can provide better reference value for clinical practice. As a new indicator, SAA is attracting more and more attention.

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).